The new COVID-19 booster shots said to target Omicron, will be released before the human trials are completed. What could possibly go wrong?
The Food and Drug Administration will be approving the new boosters sometime this week before the human testing can be finished. That means, all the data they have to “approve” these injections is incomplete, and delayed side effects or deaths won’t be considered as a part of the FDA’s “approval” process. Not that they were when the first COVID shots were released either, so this really isn’t that surprising.
According to a new report by the Wall Street Journal, the new boosters are similar to the COVID vaccines currently available in the United States with minor modifications that protect recipients from the latest version of the Omicron variant. That’s good news, considering people are now dying of SADS (sudden adult death syndrome) and getting AIDS from taking the first few injections.
Instead of waiting on data from testing these injections on humans, the agency will use data from trials in mice (which are not at all similar to humans in any way) as well as the “real-world” evidence of the safety of currently available COVID vaccines and test results from earlier iterations of boosters targeting older strains to evaluate the newest boosters, FDA Commissioner Dr. Robert Califf said.
Evidence like this:
“Real-world evidence from the current mRNA COVID-19 vaccines, which have been administered to millions of individuals, show us that the vaccines are safe,” Califf said on Twitter. “As we know from prior experience, strain changes can be made without affecting safety.”
He added that modifying existing vaccines to include protection against different viral strains doesn’t require a change in ingredient and is a common practice the FDA does with flu vaccines. “FDA has extensive experience with reviewing strain changes in vaccines, as is done with the annual flu vaccine,” Califf said.
The United Kingdom is already being subjected to these new “vaccine” boosters too. We had mentioned it wouldn’t take the U.S. long to follow suit:
At least two scientists have stepped up saying it’s a bad idea to push these vaccines on the public based on mouse data. The experts penned an op-ed demanding that the FDA not rush through the roll-out of the newest shots. “I’m uncomfortable that we would move forward — that we would give millions or tens of millions of doses to people — based on mouse data,” one of the authors, Paul Offit, told the Journal.
Offit, an FDA adviser and director of the Vaccine Education Center at Children’s Hospital of Philadelphia, believes the comparison between flu shots and COVID-19 shots is not well grounded due to the differences in mutations and protection levels.
But it’s unlikely to matter at all. Because if the ruling class wants shots that amount to genocide, that’s what they will get.